1. 袁钧瑛 中国 中国科学院 2017美国科学院院士 USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity
2. 李兰娟 中国 浙江大学 中国工程院院士 Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
3. Kojo Seys John,Elenitoba-Johnson 美国 University of Pennsylvania 2023美国医学院院士 Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis
4. 樊代明 中国 空军军医大学 中国工程院院士;2013美国医学院院士 Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on int..
5. 樊嘉 中国 复旦大学上海医学院 中国科学院院士 miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling
6. 尤启冬 中国 中国药科大学 Targeting insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) for the treatment of cancer
7. Braun, Thomas 德国 Max Planck Institute for Heart and Lung Research - W. G. Kerckhoff Institute SIRT7: a novel molecular target for personalized cancer treatment?
8. 杨惠林 中国 苏州大学 主任医师 Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and i..
9. Philippe,Lambin 荷兰 Maastricht University Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management
10. Inéz,Frerichs 德国 University of Kiel Regional ventilation distribution before and after laparoscopic lung parenchymal resection
11. 高明远 中国 苏州大学 In vivo clinical molecular imaging of T cell activity
12. Mohammad,Taheri 伊朗 SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES Current landscape of miRNAs and TGF-β signaling in lung cancer progression and therapeutic targets
13. 李萍 中国 中国药科大学 A high-throughput Gaussia luciferase reporter assay for screening potential gasdermin E activ..
14. Jo A,Van Ginderachter 比利时 Vrije University Brussel Current status and future expectations of nanobodies in oncology trials
15. Chien, Cheng-Ting 中国 台湾中央研究院 The deubiquitinase Leon/USP5 interacts with Atg1/ULK1 and antagonizes autophagy
16. Zatollah,Asemi 伊朗 Kashan University Medicine Science Melatonin targeting non-coding RNAs in cancer: Focus on mechanisms and potential therapeutic targets
17. Andreas,Scorilas 希腊 University of Athens Epi-miRNAs: Modern mediators of methylation status in human cancers
18. Ken,Shirabe 日本 Gunma University Clinicopathological features and surgical outcomes of lobectomy combined with segmentectomy: a cohor..
19. Hiroaki,Kajiyama 日本 Nagoya University Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways
20. 郭俊明 中国 宁波大学 The roles and mechanisms of circular RNAs related to mTOR in cancers